Phase 4
N/A
N/A
N/A
N/A
Not Enrolling
Both
Cancer, Venous Thromboembolism
Both
Cancer, Venous Thromboembolism
Trial Information
Inclusion Criteria:
- Cancer patients in palliative care
- Patients fully informed about their condition
- Signed informed consent
- No exclusion criteria
Exclusion Criteria:
- Absence of advanced cancer
- Cancer previously cured
- Venous thromboembolism diagnosed within 6 months prior to inclusion
- Absence of discerning capacity
- Active anti-thrombotic treatment with heparins or coumarines
- Thrombocytopenia <50G/l
- PTT >45sec
- TP<35%
- Active bleeding
- Renal failure <20ml/min
- Past history of heparin-induced thrombocytopenia
Type of Study:
Observational
Study Design:
Observational Model: Defined Population, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
Catherine Weber, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Center of Continuous Care, chemin de la Savonnière 11, CH-1245 Collonge-Bellerive
Authority:
Switzerland: Ethikkommission
Study ID:
SPOT 99/54
NCT ID:
NCT00303407
Start Date:
January 2001
Completion Date:
July 2002
Related Keywords:
- Cancer
- Venous Thromboembolism
- Thromboembolism
- Venous Thromboembolism
- Venous Thrombosis
Name | Location |
|---|
